✦ LIBER ✦

Pulmonary abnormalities in patients intravenously receiving the methanol extraction residue (MER) of bacillus calmette-guerin

✍ Scribed by Jorge R. Quesada; Herman I. Libshitz; Evan M. Hersh; Jordan U. Gutterman

Publisher: John Wiley and Sons
Year: 1980
Tongue: English
Weight: 314 KB
Volume: 45
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19800315)45:6<1340::aid-cncr2820450612>3.0.co;2-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of the methanol extraction residu

Effect of the methanol extraction residue of Bacillus Calmette-Guerin in advanced Hodgkin's disease

✍ M. Robert Cooper; Thomas F. Pajak; Nis I. Nissen; Kurt Brunner; Leon Stutzman; A 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 450 KB 👁 1 views

Chemotherapy vs. chemoimmunotherapy with

Chemotherapy vs. chemoimmunotherapy with methanol extraction residue of bacillus calmette-guerin (MER) in advanced breast cancer: A randomized trial by the piedmont oncology association

✍ Hyman B. Muss; Frederick Richards II; M. Robert Cooper; Douglas R. White; Don V. 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 597 KB

Effects of the addition of MER, a nonspecific, nonviable immunostimulant, to two combination chemotherapy programs were explored in patients with metastatic breast cancer. Patients were randomized to either CDVFP [cyclophosphamide (C), doxorubicin (D), vincristine (V), fluorouracil (F) and prednison

Combination chemotherapy-radiotherapy wi

Combination chemotherapy-radiotherapy with and without the methanol-extraction residue of bacillus calmette-guerin (MER) in small cell carcinoma of the lung a prospective randomized trial of the piedmont oncology association

✍ Don V. Jackson Jr; Barton R. Paschal; Carolyn Ferree; Frederick Richards II; Hym 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 2 views

Combination chemotherapy with and withou

Combination chemotherapy with and without the methanol-extracted residue of bacillus calmette-guerin (MER) in extensive non-small-cell lung cancer: A prospective randomized study for the piedmont oncology association

✍ Frederick Richards II; Virginia Howard; Anita Shore; Hyman B. Muss; Douglas R. W 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

One-hundred-three patients with extensive non-small-cell lung cancer were entered into a prospective, randomized trial to determine the value of MER as an adjuvant to chemotherapy. Patients were stratified according to histology and performance status. All patients received CCNU, methotrexate, and A